Pathology EMQ template.
Name:
Candidate number:
Theme:
OPTION LIST
|
A |
Adalimumab |
I |
Plasmapheresis |
|
B |
Antibody replacement therapy |
J |
TGN1412 |
|
C |
Corticosteroids |
K |
|
|
D |
Cyclophosphamide |
L |
|
|
E |
Efalizumab |
M |
|
|
F |
Influenza vaccine |
N |
|
|
G |
Interferon gamma therapy |
O |
|
|
H |
No therapy should be given |
P |
|
For each scenario below, choose the most appropriate immune therapy from the list above. Each option may be used once, more than once or not at all.
1. Patient with SLE and severe glomerulonephritis
2. Patient with a recent kidney transplant at the start of flu season
3. Side effects include iatrogenic Cushings
4. Mechanism of action is alkylating the guanine base of DNA, preventing cell replication and affecting cells with high turnover
5. Indicated for primary antibody deficiencies, including X-linked agammaglobulinaemia
ANSWERS
|
1. D |
2. F |
3. C |
4. D |
5. B |